The 2023 data reveals diverse beta-blocker daily dosage usage across countries, with Belgium leading at 66 units, while Costa Rica is significantly lower at 17 units. Notable year-on-year changes include a 2.72% increase in Estonia, contrasting with a 4.94% decline in Costa Rica. Over the past five years, the calculated Compound Annual Growth Rate (CAGR) indicates varied trends, reflecting both slight increases and declines in several countries’ beta-blocker usage.
Future trends to monitor include the impact of aging populations and advancing cardiovascular treatments, which could influence beta-blocker demand variably across different regions, potentially driving the need for adaptive healthcare strategies globally.
Top countries in Beta Blocking Medicine Use by Country
| # | 9 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Belgium | 66 | 2023 | -1.64% | -1.64% | View data |
| 2 | 2 Estonia | 62.2 | 2023 | +6.32% | +2.72% | View data |
| 3 | 3 Czech Republic | 56.8 | 2023 | -1.22% | -1.58% | View data |
| 4 | 4 Portugal | 41 | 2023 | +1.49% | +2.46% | View data |
| 5 | 5 New Zealand | 28.6 | 2023 | -0.69% | View data | |
| 6 | 6 United Kingdom | 28.6 | 2023 | -0.35% | -0.28% | View data |
| 7 | 7 Spain | 24.7 | 2023 | +0.41% | +0.41% | View data |
| 8 | 8 Canada | 24.1 | 2023 | +0.84% | -0.65% | View data |
| 9 | 9 Costa Rica | 17 | 2023 | 0% | -4.94% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
